The impact of physical activity on fatigue and quality of life in lung cancer patients: a randomised controlled trial protocol

BMC Cancer

Haryana M Dhillon³  Hidde P van der Ploeg²  Melanie L Bell³  Michael Boyer⁴  Stephen Clarke⁵  Janette Vardy¹ 

[1] Sydney Cancer Centre, Concord Repatriation General Hospital, Hospital Rd, Concord, NSW, 2137, Australia

[2] Department of Public and Occupational Health, VU University Medical Center Amsterdam, Amsterdam, The Netherlands

[3] Psycho-Oncology Co-Operative Research Group (PoCoG), School of Psychology, Faculty of Science, University of Sydney, Sydney, Australia

[4] Sydney Cancer Centre, Sydney, Australia

[5] Royal North Shore Hospital, St Leonards, Australia

关键词: Lung cancer;    Quality of life;    Fatigue;    Exercise;    Physical activity;   

Others  :  1080042
DOI  :  10.1186/1471-2407-12-572

 received in 2012-07-04, accepted in 2012-11-26,  发布年份 2012

【 摘 要 】

Background

People with lung cancer have substantial symptom burden and more unmet needs than the general cancer population. Physical activity (PA) has been shown to positively influence quality of life (QOL), fatigue and daily functioning in the curative treatment of people with breast and colorectal cancers and lung diseases, as well as in palliative settings. A randomised controlled trial (RCT) is needed to determine if lung cancer patients benefit from structured PA intervention. The

P

hysical

A

ctivity in

L

ung Cancer (PAL) trial is designed to evaluate the impact of a 2-month PA intervention on fatigue and QOL in patients with non-resectable lung cancer. Biological mechanisms will also be studied.

Methods/design

A multi-centre RCT with patients randomised to usual care or a 2-month PA programme, involving supervised PA sessions including a behavioural change component and home-based PA. QOL questionnaires, disease and functional status and body composition will be assessed at baseline, 2, 4 and 6 months follow-up. The primary endpoint is comparative levels of fatigue between the 2 arms. Secondary endpoints include: QOL, functional abilities and physical function. Exploratory endpoints include: anxiety, depression, distress, dyspnoea, PA behaviour, fitness, hospitalisations, survival, cytokines and insulin-like growth factor levels.

Discussion

This study will provide high-level evidence of the effect of PA programmes on cancer-related fatigue and QOL in patients with advanced lung cancer. If positive, the study has the potential to change care for people with cancer using a simple, inexpensive intervention to improve their QOL and help them maintain independent function for as long as possible.

Trial registration

Australian New Zealand Clinical Trials Registry No. ACTRN12609000971235

【 授权许可】

   
2012 Dhillon et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Society AC: Cancer facts & figures 2012. Atlanta: American Cancer Society; 2012.
• [2]Gloeckler LA, Eisner MP: Cancer of the lung. In SEER Survival Monograph: Cancer Survival Among Adults: US SEER Program, 1988–2001, Patient and Tumor Characteristics. Volume NIH Pub. No. 07–6215. Edited by Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J. Bethesda, MD: National Cancer Institute, SEER Program; 2007.
• [3]Luctkar-Flude MF, Groll DL, Tranmer JE, Woodend K: Fatigue and physical activity in older adults with cancer: a systematic review of the literature. Cancer Nurs 2007, 30(5):E35-45.
• [4]Joyce M, Schwartz S, Huhmann M: Supportive care in lung cancer. Semin Oncol Nurs 2008, 24(1):57-67.
• [5]Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR: Cancer-related fatigue: the scale of the problem. Oncologist 2007, 12(Suppl 1):4-10.
• [6]Forlenza MJ, Hall P, Lichtenstein P, Evengard B, Sullivan PF: Epidemiology of cancer-related fatigue in the Swedish twin registry. Cancer 2005, 104(9):2022-2031.
• [7]Dimeo F, Schwartz S, Wesel N, Voigt A, Thiel E: Effects of an endurance and resistance exercise program on persistent cancer-related fatigue after treatment. Ann Oncol 2008, 19:1495-1499.
• [8]Galvao DA, Newton RU: Review of exercise intervention studies in cancer patients. J Clin Oncol 2005, 23(4):899-909.
• [9]Stevinson C, Lawlor DA, Fox KR: Exercise interventions for cancer patients: systematic review of controlled trials. Cancer Causes Control 2004, 15(10):1035-1056.
• [10]Lacasse Y, Goldstein R, Lasserson TJ, Martin S: Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006, (4):CD003793.
• [11]Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA: Physical activity and survival after breast cancer diagnosis. JAMA 2005, 293(20):2479-2486.
• [12]Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS: Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 2006, 24(22):3527-3534.
• [13]Meyerhardt JA, Heseltine D, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Nelson H, Whittom R, Hantel A, et al.: Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 2006, 24(22):3535-3541.
• [14]Haydon AM, Macinnis RJ, English DR, Giles GG: Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut 2006, 55(1):62-67.
• [15]Meyerhardt JA, Giovannucci EL, Ogino S, Kirkner GJ, Chan AT, Willett W, Fuchs CS: Physical activity and male colorectal cancer survival. Arch Intern Med 2009, 169(22):2102-2108.
• [16]Ballard-Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, McTiernan A, Alfano CM: Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst 2012, 104:815-840.
• [17]World Health Organisation: Global recommendations on physical activity for health. Geneva, Switzerland: World Health Organization; 2010.
• [18]Lynch BM, Cerin E, Owen N, Aitken JF: Associations of leisure-time physical activity with quality of life in a large, population-based sample of colorectal cancer survivors. Cancer Causes Control 2007, 18(7):735-742.
• [19]Courneya KS, Friedenreich CM, Quinney HA, Fields AL, Jones LW, Fairey AS: A randomized trial of exercise and quality of life in colorectal cancer survivors. Eur J Cancer Care 2003, 12(4):347-357.
• [20]Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G: Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J Clin Oncol 2005, 23(16):3830-3842.
• [21]Oldervoll LM, Loge JH, Paltiel H, Asp MB, Vidvei U, Wiken AN, Hjermstad MJ, Kaasa S: The effect of a physical exercise program in palliative care: a phase II study. J Pain Symptom Manage 2006, 31(5):421-430.
• [22]Wiggins MS, Simonavice EM: Cancer prevention, aerobic capacity, and physical functioning in survivors related to physical activity: a recent review. Cancer Manage Res 2010, 2:157-164.
• [23]Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH: An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv: Res and Pract 2010, 4(2):87-100.
• [24]Schmitz KH, Holtzman J, Courneya KS, Masse LC, Duval S, Kane R: Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2005, 14(7):1588-1595.
• [25]Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, et al.: American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci in Sports Exerc 2010, 42(7):1409-1426.
• [26]Bellizzi KM, Rowland JH, Jeffery DD, McNeel T: Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol 2005, 23(34):8884-8893.
• [27]Courneya KS, Katzmarzyk P, Bacon E: Physical activity and obesity in canadian cancer survivors: population-based estimates from the 2005 canadian community health survey. Cancer 2008, 112(11):2475-82.
• [28]Coups EJ, Ostroff JS: A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Prev Med 2005, 40(6):702-711.
• [29]Oh B, Butow P, Mullan B, Clarke S, Beale P, Pavlakis N, Kothe E, Lam L, Rosenthal D: Impact of medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial. Ann Oncol 2012, 21(3):608-614.
• [30]Azjen I: The theory of planned behavior. Organ Behav Hum Decis Process 1991, 50:179-211.
• [31]Jones LW, Eves ND, Mackey JR, Peddle CJ, Haykowsky M, Joy AA, Courneya KS, Tankel K, Spratlin J, Reiman T: Safety and feasibility of cardiopulmonary exercise testing in patients with advanced cancer. Lung cancer (Amsterdam, Netherlands) 2007, 55(2):225-232.
• [32]McTiernan A: Mechanisms linking physical activity with cancer. Nat Rev 2008, 8(3):205-211.
• [33]Friedenreich CM, Orenstein MR: Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 2002, 132(11 Suppl):3456S-3464S.
• [34]Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR: Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 2003, 12(8):721-727.
• [35]Irwin ML, Varma K, Alvarez-Reeves M, Cadmus L, Wiley A, Chung GG, Dipietro L, Mayne ST, Yu H: Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the yale exercise and survivorship study. Cancer Epidemiol Biomarkers Prev 2009, 18(1):306-313.
• [36]Jakes RW, Day NE, Patel B, Khaw KT, Oakes S, Luben R, Welch A, Bingham S, Wareham NJ: Physical inactivity is associated with lower forced expiratory volume in 1 second: European prospective investigation into cancer-Norfolk prospective population study. Am J Epidemiol 2002, 156(2):139-147.
• [37]Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ 2nd: Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995, 332(18):1198-1203.
• [38]Thomas S, Reading J, Shephard RJ: Revision of the physical activity readiness questionnaire (PAR-Q). Can J Sport Sci = Journal canadien des sciences du sport 1992, 17(4):338-345.
• [39]Ajzen I: The theory of planned behavior. Organ Behav Hum Decis Process 1991, 50:179-211.
• [40]Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346(6):393-403.
• [41]Rikli R, Jones CJ: Senior fitness test manual. Champaign, IL: Human Kinetics; 2001.
• [42]Bohannon RW: Hand-grip dynamometry provides a valid indication of upper extremity strength impairment in home care patients. J Hand Ther: official journal of the American Society of Hand Therapists 1998, 11(4):258-260.
• [43]Plasqui G, Westerterp KR: Physical activity assessment with accelerometers: an evaluation against doubly labeled water. Obes (Silver Spring) 2007, 15(10):2371-2379.
• [44]Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E: Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997, 13(2):63-74.
• [45]Cella D, Davis K, Breitbart W, Curt G: Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 2001, 19(14):3385-3391.
• [46]Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M: The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC study group on quality of life. Eur J Cancer 1994, 30A(5):635-642.
• [47]Thomas VS, Rockwood K, McDowell I: Multidimensionality in instrumental and basic activities of daily living. J Clin Epidemiol 1998, 51(4):315-321.
• [48]Goldberg DP: A user's guide to the general health questionnaire. Windsor, UK: NFER-Nelson; 1991.
• [49]Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE: Screening and referral for psychosocial distress in oncologic practice: use of the distress thermometer. Cancer 2008, 113(4):870-878.
• [50]Wagner L, Sweet J, Butt Z, Lai J, Cella D: Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy - cognitive function instrument. J Support Oncol 2009, 7(6):W32-W39.
• [51]Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ: The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28(2):193-213.
• [52]Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM: Validation of a new dyspnea measure: the UCSD shortness of breath questionnaire. University of California, San Diego. Chest 1998, 113(3):619-624.
• [53]Brown WJ, Trost SG, Bauman A, Mummery K, Owen N: Test-retest reliability of four physical activity measures used in population surveys. J Sci Med Sport / Sports Med Aust 2004, 7(2):205-215.
• [54]Marshall AL, Miller YD, Burton NW, Brown WJ: Measuring total and domain-specific sitting: a study of reliability and validity. Med Sci Sports Exerc 2010, 42(6):1094-1102.
• [55]Courneya KS, Friedenreich CM, Reid RD, Gelmon K, Mackey JR, Ladha AB, Proulx C, Vallance JK, Segal RJ: Predictors of follow-up exercise behavior 6 months after a randomized trial of exercise training during breast cancer chemotherapy. Breast Cancer Res Treat 2009, 114:179-187.
• [56]Colinet B, Jacot W, Bertrand D, Lacombe S, Bozonnat MC, Daures JP, Pujol JL: A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index. Br J Cancer 2005, 93(10):1098-1105.
• [57]Cella D, Eton DT, Lai JS, Peterman AH, Merkel DE: Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 2002, 24(6):547-561.
• [58]National Research Council: Panel on handling missing data in clinical trials. The prevention and treatment of missing data in clinical trials. Washington DC: Pres NA; 2010. [Committee on national statistics, division of behavioral and social sciences and education]
• [59]Fitzmaurice GM, Laird NM, Ware JH: Applied longitudinal analysis. 2nd edition. Hoboken NJ: Wiley; 2011.
• [60]White IR, Horton NJ, Carpenter J, Pocock SJ: Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ 2011, 342:d40.
• [61]Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, Zuwallack R, Herrerias C: Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest 2007, 131(5 Suppl):4S-42S.